Telstra Group Ltd
TLS
Woodside Energy Group Ltd
WDS
CommBank
CBA
ANZ Group Holdings Ltd
ANZ
National Australia Bank Ltd
NAB
AU Stock MarketDetailed Quotes
PXS Pharmaxis Ltd
- 0.027
- 0.0000.00%
20min DelayMarket Closed Apr 12 10:00 AET
19.51MMarket Cap-1.59P/E (Static)
0.000High0.000Low0Volume0.000Open0.027Pre Close0.00Turnover0.03052wk High0.00%Turnover Ratio722.61MShares0.02652wk Low-0.017EPS TTM8.93MFloat Cap0.150Historical HighLossP/E (Static)330.70MShs Float0.026Historical Low-0.017EPS LYR0.00%Amplitude--Dividend TTM2.08P/B1Lot Size--Div YieldTTM
Pharmaxis Ltd News
Pharmaxis Ltd: Syntara Receives $5m R&D Tax Incentive
Pharmaxis Ltd: Change of Director's Interest Notice - GP
Pharmaxis Ltd: Chair's Address to Shareholders
Pharmaxis Ltd: First patient dosed in Phase 2 trial of sleep disorder
Pharmaxis Ltd: Quarterly Activities Report
Pharmaxis Ltd: Quarterly Appendix 4C Cash Flow Report
Pharmaxis Ltd: PXS Quarterly Shareholder Update and Investor Call
Pharmaxis Ltd: Appendix 4G
Pharmaxis Ltd: Corporate Governance Statement
Pharmaxis Ltd: Pharmaxis Completes Sale of Mannitol Business
Pharmaxis Ltd: Final Directors Interest Notice
Pharmaxis Ltd: Final Directors Interest Notice
Pharmaxis Ltd: Trading Halt
Pharmaxis Ltd: Date of Virtual AGM Date for Receipt of Director Nominations
Pharmaxis Ltd: Nature Cancer Publishes Results of PXS Garvin Collaboration
Pharmaxis Ltd: PXS to Receive Prepayment of 2023 Research Tax Incentive
Pharmaxis Ltd: Quarterly Activities Report
Pharmaxis Ltd: Quarterly Appendix 4C Cash Flow Report
Pharmaxis Ltd: Pharmaxis Quarterly Shareholder Update and Investor Briefing
Pharmaxis Ltd: PXS to Present at MST Access Biotech Hidden Gems Forum